Literature DB >> 12675686

Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study.

E Hawe1, P J Talmud, G J Miller, S E Humphries.   

Abstract

We have estimated the risk of coronary heart disease (CHD) from family history of CHD (FHCHD) in 2827 healthy European middle-aged men, and explored the extent to which this can be explained by classical and genetic risk factors. Men with FHCHD (obtained by questionnaire) had a hazard ratio of CHD of 1.73 (95% confidence interval: 1.30, 2.31) compared to those without FHCHD; after adjusting for classical risk factors this did not change substantially. Those with FHCHD had 2.3% lower Factor VIIc (p = 0.03) and 1.14% higher systolic and 1.21% higher diastolic blood pressure (p = 0.04 and p = 0.02), with evidence of interaction between blood pressure and FHCHD status on risk (p = 0.01). The risk for those with a positive family history who were also current smokers was 3.01 compared to non-smokers without FHCHD, which is greater than the risk posed by smoking or FHCHD alone (1.96 and 2.05 respectively compared to non-smokers without FHCHD), but not significantly different from a multiplicative model (p-value for interaction 0.33). Allele frequencies for 13 candidate gene variants were not significantly different between those with and without FHCHD. In those with FHCHD, current smokers who carried the APOE4 allele (e4+) had a hazard ratio of 5.66 compared to non-smokers who had no FHCHD and were not APOE4+, with a significant interaction between smoking and APOE4 in those with FHCHD p = 0.001. These data demonstrate the complex interaction between genetic and environmental factors in determining CHD risk, and suggest that the causes of the familial clustering of CHD remain largely unexplained.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675686     DOI: 10.1046/j.1469-1809.2003.00017.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  19 in total

1.  Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes.

Authors:  J Hartweg; A J Farmer; R R Holman; H A W Neil
Journal:  Diabetologia       Date:  2006-11-21       Impact factor: 10.122

Review 2.  Genetics and heritability of coronary artery disease and myocardial infarction.

Authors:  Björn Mayer; Jeanette Erdmann; Heribert Schunkert
Journal:  Clin Res Cardiol       Date:  2006-10-10       Impact factor: 5.460

Review 3.  Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.

Authors:  C K Chow; A C H Pell; A Walker; C O'Dowd; A F Dominiczak; J P Pell
Journal:  BMJ       Date:  2007-09-08

4.  The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study.

Authors:  Braxton D Mitchell; Patrick F McArdle; Haiqing Shen; Evadnie Rampersaud; Toni I Pollin; Lawrence F Bielak; Cashell Jaquish; Julie A Douglas; Marie-Hélène Roy-Gagnon; Paul Sack; Rosalie Naglieri; Scott Hines; Richard B Horenstein; Yen-Pei C Chang; Wendy Post; Kathleen A Ryan; Nga Hong Brereton; Ruth E Pakyz; John Sorkin; Coleen M Damcott; Jeffrey R O'Connell; Charles Mangano; Mary Corretti; Robert Vogel; William Herzog; Matthew R Weir; Patricia A Peyser; Alan R Shuldiner
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

5.  Should statin therapy be allocated on the basis of global risk or on the basis of randomized trial evidence?

Authors:  Deeptankar DeMazumder; Rani K Hasan; Roger S Blumenthal; Erin D Michos; Steven Jones
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

6.  Prevalence Pattern of Risk Factors for Coronary Artery Disease among Patients Presenting for Coronary Artery Bypass Grafting in Oman.

Authors:  Rajeeva Rivikath Pieris; Hilal Ali Al-Sabti; Qasim Saleh Abdullah Al-Abri; Syed Gauhar Alam Rizvi
Journal:  Oman Med J       Date:  2014-05

7.  Screening families of patients with premature coronary heart disease to identify avoidable cardiovascular risk: a cross-sectional study of family members and a general population comparison group.

Authors:  Helen J Thompson; Alastair Ch Pell; Judith Anderson; Clara K Chow; Jill P Pell
Journal:  BMC Res Notes       Date:  2010-05-11

Review 8.  Cardiovascular genomics.

Authors:  Shu-Fen Wung; Kathleen T Hickey; Jacquelyn Y Taylor; Matthew J Gallek
Journal:  J Nurs Scholarsh       Date:  2013-01-31       Impact factor: 3.176

9.  Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol.

Authors:  Nadeem Qureshi; Sarah Armstrong; Paula Saukko; Tracey Sach; Jo Middlemass; Phil H Evans; Joe Kai; Hannah Farrimond; Steve E Humphries
Journal:  BMC Health Serv Res       Date:  2009-10-12       Impact factor: 2.655

10.  Effects of data preprocessing on results of the epidemiological analysis of coronary heart disease and behaviour-related risk factors.

Authors:  Ari Voutilainen; Christina Brester; Mikko Kolehmainen; Tomi-Pekka Tuomainen
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.